This opinion review summarizes current knowledge in the field and addresses the future
direction of rTMS treatment in MDD, facilitating the establishment of this clinical intervention …

Repetitive Transcranial Magnetic Stimulation (rTMS) has been approved by the FDA as an
effective intervention for Treatment-Resistant Depression (TRD). However, there is little …

Background Repetitive transcranial magnetic stimulation (rTMS) is an increasingly used
treatment for patients with depression. The use of rTMS in depression is supported by over …

Background Repetitive transcranial magnetic stimulation (rTMS) is frequently used as an
adjunctive treatment with antidepressants for depression. We aimed to evaluate the clinical …

With the ability to modulate cortical activity, repetitive transcranial magnetic stimulation
(rTMS) is becoming increasingly important in clinical applications for psychiatric disorders …

Major depressive disorder is a highly prevalent condition with significant morbidity and
mortality. Recurrent episodes occur in greater than 50% of patients within a one year period …

Background A dearth of evidence-based information exists to guide the delivery of
transcranial magnetic stimulation (TMS) after a successful acute course of treatment for …

Repetitive transcranial magnetic stimulation (rTMS) treatment is widely accepted as an
evidence-based treatment option for depression and anxiety. However, the underlying …

Repetitive transcranial magnetic stimulation (rTMS) may have the potential to prevent
depressive relapse. This assessor-blinded, randomized controlled study was designed to …

Repetitive transcranial magnetic stimulation (rTMS) for patients with treatment-resistant
depression (TRD) became covered by the National Health Insurance (NHI) in Japan since …